Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report.

Tevimbra (tislelizumab-jsgr) - BeOne Medicines

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

http://www.ncbi.nlm.nih.gov/pubmed/42529120

Jiao Chen; Juanjuan Hu; Ke Li; Ruiqing Luo; Xueliang Qi; Ye Tian; Zhiji Gan

Jul 31, 2026